|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
p-Nitrochlorobenzene |
CAS 100-00-5 | ||
ClC6H4NO2 |
RTECS CZ1050000 | ||
|
Synonyms & Trade Names p-Chloronitrobenzene, 4-Chloronitrobenzene, 1-Chloro-4-nitrobenzene, 4-Nitrochlorobenzene, PCNB, PNCB |
DOT ID & Guide 1578 152 |
||
Exposure
|
NIOSH REL: Ca See Appendix A [skin] | ||
| OSHA PEL: TWA 1 mg/m3 [skin] | |||
| IDLH Ca [100 mg/m3] See: 100005 | Conversion | ||
|
Physical Description Yellow, crystalline solid with a sweet odor. |
|||
|
MW: 157.6 |
BP: 468°F |
MLT: 182°F |
Sol: Slight |
|
VP(86°F): 0.2 mmHg |
IP: 9.96 eV |
|
Sp.Gr: 1.52 |
|
Fl.P: 261°F |
UEL: ? |
LEL: ? |
|
| Solid that does not burn, or burns with difficulty. | |||
|
Incompatibilities & Reactivities Strong oxidizers, alkalis |
|||
|
Measurement Methods NIOSH 2005 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Anoxia; unpleasant taste; anemia; methemoglobinemia; in animals: hematuria (blood in the urine); spleen, kidney, bone marrow changes; reproductive effects; [potential occupational carcinogen] | |
|
Target Organs
Blood, liver, kidneys, cardiovascular system, spleen, bone marrow, reproductive system Cancer Site [in animals: vascular & liver tumors] |
|
| See also: INTRODUCTION See ICSC CARD: 0846 See MEDICAL TESTS: 0163 |